Chromatin immunoprecipitation (ChIP) and luciferase assays further confirmed TR4 modulation of CCL2 at the transcriptional level, and addition of the CCL2 receptor antagonist interrupted the TR4-enhanced PCa cells migration/invasion. This evidence concerns the gene NR2C2 and posterior cortical atrophy.